Literature DB >> 17924208

Irinotecan-induced central nervous system toxicity. Report on two cases and review of the literature.

Paul Hamberg, Floris A De Jong, Dieta Brandsma, Jaap Verweij, Stefan Sleijfer.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 17924208     DOI： 10.1080/02841860701666089

Source DB:  PubMed          Journal:  Acta Oncol        ISSN： 0284-186X            Impact factor:   4.089


× No keyword cloud information.
  8 in total

Review 1.  Drug-induced cerebellar ataxia: a systematic review.

Authors:  J van Gaalen; F G Kerstens; R P P W M Maas; L Härmark; B P C van de Warrenburg
Journal:  CNS Drugs       Date:  2014-12       Impact factor: 5.749

2.  FOLFIRINOX-induced reversible dysarthria: A case report and review of previous cases.

Authors:  Ayumu Matsuoka; Osamu Maeda; Megumi Inada-Inoue; Eizaburo Ohno; Yoshiki Hirooka; Yukihiro Yokoyama; Tsutomu Fujii; Masato Nagino; Hidemi Goto; Yuichi Ando
Journal:  Oncol Lett       Date:  2015-08-11       Impact factor: 2.967

3.  Identification of early gene expression changes in primary cultured neurons treated with topoisomerase I poisons.

Authors:  Sharyn L Rossi; Casey J Lumpkin; Ashlee W Harris; Jennifer Holbrook; Cinsley Gentillon; Suzanne M McCahan; Wenlan Wang; Matthew E R Butchbach
Journal:  Biochem Biophys Res Commun       Date:  2016-09-15       Impact factor: 3.575

Review 4.  FOLFIRINOX for locally advanced and metastatic pancreatic cancer: single institution retrospective review of efficacy and toxicity.

Authors:  Krishna S Gunturu; Xiaopan Yao; Xiangyu Cong; Jaykumar R Thumar; Howard S Hochster; Stacey M Stein; Jill Lacy
Journal:  Med Oncol       Date:  2012-12-28       Impact factor: 3.064

5.  Achievement of three year remission with bevacizumab and irinotecan in recurrent glioblastoma multiforme: a case report.

Authors:  Abhirami Vivekanandarajah; Balakumar Krishnarasa; Mervat Mourad; Nelly Aoun; Marcel Odaimi
Journal:  Clin Med Insights Oncol       Date:  2011-02-14

6.  Irinotecan-induced dysarthria.

Authors:  Albertine J Dressel; Johannes C van der Mijn; Ijke J Aalders; Rico N P M Rinkel; Hans J van der Vliet
Journal:  Case Rep Oncol       Date:  2012-01-18

7.  Severe Generalized Weakness, Paralysis, and Aphasia following Administration of Irinotecan and Oxaliplatin during FOLFIRINOX Chemotherapy.

Authors:  Manisha Chandar; Robert de Wilton Marsh
Journal:  Case Rep Oncol       Date:  2015-03-04

8.  Irinotecan-Associated Dysarthria in Patients with Pancreatic Cancer: A Single Site Experience.

Authors:  Ali Elbeddini; Naushin Hooda; Mohamed Gazarin; Penny Webster; Jackie McMillan
Journal:  Am J Case Rep       Date:  2020-06-28
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.